<p>CVS Health（紐約證券交易所代碼：CVS - 獲取免費報告）在週三發佈的報告中，投資分析師將其目標股價從 93.00 美元上調至 95.00 美元，MarketScreener 報道。該公司目前對這家藥房運營商的股票給予 “買入” 評級。摩根士丹利的目標價暗示該股票相較於之前的收盤價有 21.03% 的潛在上漲空間。</p>
<ul>
<li>CVS Health 因收入增長而上漲，股息保持強勁</li>
</ul>
<p>其他一些股票分析師也最近對該公司發表了看法。Raymond James Financial 在 10 月 31 日的報告中將 CVS Health 的目標股價從 75.00 美元上調至 90.00 美元。Wolfe Research 在週一將 CVS Health 的目標股價從 85.00 美元上調至 100.00 美元，並給予該股票 “跑贏大盤” 的評級。Weiss Ratings 在週一的研究報告中重申了對 CVS Health 股票的 “持有（c-）” 評級。Mizuho 在週三將 CVS Health 的目標股價從 88.00 美元上調至 95.00 美元，並給予該股票 “跑贏大盤” 的評級。最後，巴克萊在週三將 CVS Health 的目標價從 87.00 美元上調至 93.00 美元，並給予該公司 “增持” 評級。有兩位分析師給予該股票 “強烈買入” 評級，二十位分析師給予 “買入” 評級，四位分析師給予 “持有” 評級。根據 MarketBeat 的數據，CVS Health 的平均評級為 “適度買入”，平均目標股價為 93.43 美元。</p>
<p><strong>獲取我們關於 CVS Health 的最新研究報告</strong></p>
<h2>CVS Health 價格表現</h2>
<ul>
<li>MarketBeat 週迴顧 – 05/12 - 05/16</li>
</ul>
<p>紐約證券交易所：CVS 在週三開盤價為 78.50 美元。該公司的 50 日移動平均價格為 78.87 美元，200 日移動平均價格為 71.64 美元。CVS Health 的 1 年最低價為 43.56 美元，1 年最高價為 85.15 美元。該公司的市值為 996.5 億美元，市盈率為 208.57，市盈增長比率為 0.76，貝塔係數為 0.48。該公司的債務股本比率為 0.83，流動比率為 0.83，速動比率為 0.63。</p>
<p>CVS Health（紐約證券交易所代碼：CVS - 獲取免費報告）在 10 月 29 日週三發佈了季度財報。該藥房運營商報告季度每股收益為 1.60 美元，超出市場共識預期的 1.36 美元，超出 0.24 美元。該公司季度收入為 1028.7 億美元，而分析師預期為 988.5 億美元。CVS Health 的淨利潤率為 0.12%，股本回報率為 11.45%。該公司的收入同比增長 7.8%。去年同期，該公司每股收益為 1.09 美元。CVS Health 已將其 2025 財年的指導目標設定為 6.550-6.650 美元每股收益。股票研究分析師預測 CVS Health 在當前年度將發佈 5.89 美元每股收益。</p>
<h2>CVS Health 的機構交易</h2>
<ul>
<li>現在是買入 Novo Nordisk 股票的時機嗎？</li>
</ul>
<p>大型投資者最近買入和賣出了該公司的股票。Severin Investments LLC 在第三季度將其在 CVS Health 的持股比例提高了 124.9%。Severin Investments LLC 現在擁有 14,789 股該藥房運營商的股票，價值 1,115,000 美元，此前在上個季度購買了 8,212 股。Allworth Financial LP 在第三季度將其在 CVS Health 的持股增加了 7.2%。Allworth Financial LP 現在擁有 28,764 股該藥房運營商的股票，價值 2,169,000 美元，此前在上個季度購買了 1,922 股。IFP Advisors Inc 在第三季度將其在 CVS Health 的持股提高了 5.6%。IFP Advisors Inc 現在擁有 25,463 股該藥房運營商的股票，價值 1,920,000 美元，此前在上個季度購買了 1,345 股。Steadtrust LLC 在第三季度將其在 CVS Health 的持股提高了 1.8%。Steadtrust LLC 現在擁有 10,175 股該藥房運營商的股票，價值 767,000 美元，此前在上個季度購買了 175 股。最後，CIBC Bancorp USA Inc.在第三季度購買了 CVS Health 的新股份，價值 13,183,000 美元。對沖基金和其他機構投資者持有該公司 80.66% 的股份。</p>
<h2>CVS Health 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>CVS Health Corporation 在美國提供健康解決方案。它通過醫療保險、健康服務和藥房及消費者健康部門運營。醫療保險部門提供傳統、自願和消費者導向的健康保險產品及相關服務。</p>
<h2>瞭解更多</h2>
<ul>
<li>我們更看好的五隻股票超過 CVS Health</li>
<li>股息貴族名單中的最佳：通過貴族指數積累財富</li>
<li>錯過了 NVIDIA？Braze 可能是下一個 AI 股票突破</li>
<li>如何交易便士股票：逐步指南</li>
<li>沃爾瑪的納斯達克切換可能改變 WMT 股票的一切</li>
<li>萬億美元市值的意義超越數字本身</li>
<li>GameStop 看起來破碎：這就是為什麼 GME 可能在 2026 年崩潰</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 CVS Health 嗎？</h2>
<p>在考慮 CVS Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前立即購買……而 CVS Health 不在名單上。</p>
<p>雖然 CVS Health 目前在分析師中獲得 “適度買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

西維斯

<p>高盛將 CVS Health 的目標股價從 93 美元上調至 95 美元，維持 “買入” 評級，暗示潛在上漲幅度為 21.03%。其他分析師也提高了他們的目標，CVS Health 獲得了 “適度買入” 的平均評級。該公司報告了強勁的季度收益，營收同比增長 7.8%。機構投資者積極交易 CVS Health 的股票，持股比例達到 80.66%。CVS Health 在醫療保健福利、服務和藥房領域運營</p>

<p>CVS Health (NYSE:CVS - Get Free Report) had its price target raised by investment analysts at The Goldman Sachs Group from $93.00 to $95.00 in a report issued on Wednesday,MarketScreener reports. The firm presently has a &#34;buy&#34; rating on the pharmacy operator's stock. The Goldman Sachs Group's price objective suggests a potential upside of 21.03% from the stock's previous close.</p>
<div class="lb-trans"><p>CVS Health（紐約證券交易所代碼：CVS - 獲取免費報告）在週三發佈的報告中，投資分析師將其目標股價從 93.00 美元上調至 95.00 美元，MarketScreener 報道。該公司目前對這家藥房運營商的股票給予 “買入” 評級。摩根士丹利的目標價暗示該股票相較於之前的收盤價有 21.03% 的潛在上漲空間。</p>
</div><ul>
<li>CVS Health Gains as Revenue Grows, Dividend Remains Strong</li>
</ul>
<div class="lb-trans"><ul>
<li>CVS Health 因收入增長而上漲，股息保持強勁</li>
</ul>
</div><p>A number of other equities analysts have also recently weighed in on the company. Raymond James Financial upped their price target on CVS Health from $75.00 to $90.00 in a report on Friday, October 31st. Wolfe Research upped their target price on CVS Health from $85.00 to $100.00 and gave the stock an &#34;outperform&#34; rating in a research note on Monday. Weiss Ratings reiterated a &#34;hold (c-)&#34; rating on shares of CVS Health in a research report on Monday. Mizuho boosted their price target on shares of CVS Health from $88.00 to $95.00 and gave the stock an &#34;outperform&#34; rating in a report on Wednesday. Finally, Barclays increased their price objective on shares of CVS Health from $87.00 to $93.00 and gave the company an &#34;overweight&#34; rating in a report on Wednesday. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, CVS Health has an average rating of &#34;Moderate Buy&#34; and an average target price of $93.43.</p>
<div class="lb-trans"><p>其他一些股票分析師也最近對該公司發表了看法。Raymond James Financial 在 10 月 31 日的報告中將 CVS Health 的目標股價從 75.00 美元上調至 90.00 美元。Wolfe Research 在週一將 CVS Health 的目標股價從 85.00 美元上調至 100.00 美元，並給予該股票 “跑贏大盤” 的評級。Weiss Ratings 在週一的研究報告中重申了對 CVS Health 股票的 “持有（c-）” 評級。Mizuho 在週三將 CVS Health 的目標股價從 88.00 美元上調至 95.00 美元，並給予該股票 “跑贏大盤” 的評級。最後，巴克萊在週三將 CVS Health 的目標價從 87.00 美元上調至 93.00 美元，並給予該公司 “增持” 評級。有兩位分析師給予該股票 “強烈買入” 評級，二十位分析師給予 “買入” 評級，四位分析師給予 “持有” 評級。根據 MarketBeat 的數據，CVS Health 的平均評級為 “適度買入”，平均目標股價為 93.43 美元。</p>
</div><p><strong>Get Our Latest Research Report on CVS Health</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 CVS Health 的最新研究報告</strong></p>
</div><h2>CVS Health Price Performance</h2>
<div class="lb-trans"><h2>CVS Health 價格表現</h2>
</div><ul>
<li>MarketBeat Week in Review – 05/12 - 05/16</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 05/12 - 05/16</li>
</ul>
</div><p>NYSE:CVS opened at $78.50 on Wednesday. The company has a 50 day moving average price of $78.87 and a 200-day moving average price of $71.64. CVS Health has a 1-year low of $43.56 and a 1-year high of $85.15. The firm has a market cap of $99.65 billion, a price-to-earnings ratio of 208.57, a price-to-earnings-growth ratio of 0.76 and a beta of 0.48. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63.</p>
<div class="lb-trans"><p>紐約證券交易所：CVS 在週三開盤價為 78.50 美元。該公司的 50 日移動平均價格為 78.87 美元，200 日移動平均價格為 71.64 美元。CVS Health 的 1 年最低價為 43.56 美元，1 年最高價為 85.15 美元。該公司的市值為 996.5 億美元，市盈率為 208.57，市盈增長比率為 0.76，貝塔係數為 0.48。該公司的債務股本比率為 0.83，流動比率為 0.83，速動比率為 0.63。</p>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm's revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the business earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts forecast that CVS Health will post 5.89 EPS for the current year.</p>
<div class="lb-trans"><p>CVS Health（紐約證券交易所代碼：CVS - 獲取免費報告）在 10 月 29 日週三發佈了季度財報。該藥房運營商報告季度每股收益為 1.60 美元，超出市場共識預期的 1.36 美元，超出 0.24 美元。該公司季度收入為 1028.7 億美元，而分析師預期為 988.5 億美元。CVS Health 的淨利潤率為 0.12%，股本回報率為 11.45%。該公司的收入同比增長 7.8%。去年同期，該公司每股收益為 1.09 美元。CVS Health 已將其 2025 財年的指導目標設定為 6.550-6.650 美元每股收益。股票研究分析師預測 CVS Health 在當前年度將發佈 5.89 美元每股收益。</p>
</div><h2>Institutional Trading of CVS Health</h2>
<div class="lb-trans"><h2>CVS Health 的機構交易</h2>
</div><ul>
<li>Is It Time to Buy the Dip in Novo Nordisk Stock?</li>
</ul>
<div class="lb-trans"><ul>
<li>現在是買入 Novo Nordisk 股票的時機嗎？</li>
</ul>
</div><p>Large investors have recently bought and sold shares of the business. Severin Investments LLC lifted its stake in CVS Health by 124.9% in the 3rd quarter. Severin Investments LLC now owns 14,789 shares of the pharmacy operator's stock worth $1,115,000 after purchasing an additional 8,212 shares in the last quarter. Allworth Financial LP increased its holdings in shares of CVS Health by 7.2% in the third quarter. Allworth Financial LP now owns 28,764 shares of the pharmacy operator's stock valued at $2,169,000 after purchasing an additional 1,922 shares during the last quarter. IFP Advisors Inc lifted its position in CVS Health by 5.6% during the third quarter. IFP Advisors Inc now owns 25,463 shares of the pharmacy operator's stock worth $1,920,000 after buying an additional 1,345 shares in the last quarter. Steadtrust LLC boosted its stake in CVS Health by 1.8% during the third quarter. Steadtrust LLC now owns 10,175 shares of the pharmacy operator's stock worth $767,000 after buying an additional 175 shares during the last quarter. Finally, CIBC Bancorp USA Inc. purchased a new stake in CVS Health in the 3rd quarter valued at $13,183,000. Hedge funds and other institutional investors own 80.66% of the company's stock.</p>
<div class="lb-trans"><p>大型投資者最近買入和賣出了該公司的股票。Severin Investments LLC 在第三季度將其在 CVS Health 的持股比例提高了 124.9%。Severin Investments LLC 現在擁有 14,789 股該藥房運營商的股票，價值 1,115,000 美元，此前在上個季度購買了 8,212 股。Allworth Financial LP 在第三季度將其在 CVS Health 的持股增加了 7.2%。Allworth Financial LP 現在擁有 28,764 股該藥房運營商的股票，價值 2,169,000 美元，此前在上個季度購買了 1,922 股。IFP Advisors Inc 在第三季度將其在 CVS Health 的持股提高了 5.6%。IFP Advisors Inc 現在擁有 25,463 股該藥房運營商的股票，價值 1,920,000 美元，此前在上個季度購買了 1,345 股。Steadtrust LLC 在第三季度將其在 CVS Health 的持股提高了 1.8%。Steadtrust LLC 現在擁有 10,175 股該藥房運營商的股票，價值 767,000 美元，此前在上個季度購買了 175 股。最後，CIBC Bancorp USA Inc.在第三季度購買了 CVS Health 的新股份，價值 13,183,000 美元。對沖基金和其他機構投資者持有該公司 80.66% 的股份。</p>
</div><h2>CVS Health Company Profile</h2>
<div class="lb-trans"><h2>CVS Health 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy &amp; Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.</p>
<div class="lb-trans"><p>CVS Health Corporation 在美國提供健康解決方案。它通過醫療保險、健康服務和藥房及消費者健康部門運營。醫療保險部門提供傳統、自願和消費者導向的健康保險產品及相關服務。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index</li>
<li>Missed NVIDIA? Braze Might Be the Next AI Stock Breakout</li>
<li>How to trade penny stocks: A step-by-step guide</li>
<li>Walmart’s NASDAQ Switch Could Change Everything for WMT Stock</li>
<li>The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number</li>
<li>GameStop Looks Broken: Here’s Why GME Could Crash in 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票超過 CVS Health</li>
<li>股息貴族名單中的最佳：通過貴族指數積累財富</li>
<li>錯過了 NVIDIA？Braze 可能是下一個 AI 股票突破</li>
<li>如何交易便士股票：逐步指南</li>
<li>沃爾瑪的納斯達克切換可能改變 WMT 股票的一切</li>
<li>萬億美元市值的意義超越數字本身</li>
<li>GameStop 看起來破碎：這就是為什麼 GME 可能在 2026 年崩潰</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 CVS Health 嗎？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 CVS Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前立即購買……而 CVS Health 不在名單上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 CVS Health 目前在分析師中獲得 “適度買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

高盛集團將西維斯（NYSE:CVS）的目標價上調至 95.00 美元